Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.2)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Open Access
Clockss

Neuroinflammation in CNS Disorders

From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder Research

 

Advances in Clinical and Experimental Medicine

Adv Clin Exp Med

 

Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Neuroinflammation in CNS Disorders

 

The editors of this special collection invite submissions exploring the latest advances in clinical and experimental research on neuroinflammation in the central nervous system (CNS). Neuroinflammation is at the forefront of neuroscience, shaping our understanding of CNS disorders such as neurodegenerative disease, psychiatric disorders, and traumatic brain injuries. This collection aims to unite diverse perspectives, fostering insights into the complex cellular and molecular mechanisms driving neuroinflammatory processes. We encourage the submission of original research, meta-analyses, and comprehensive review articles that shed light on diagnostic, therapeutic, and mechanistic aspects of CNS inflammation.

We are particularly interested in manuscripts that explore the interplay between immune cells, neurons, and glia, with a focus on translational research. Contributions detailing innovative diagnostic approaches, therapeutic targets, or computational models are highly welcome. Join this effort to advance the boundaries of neuroinflammation research and contribute to groundbreaking findings that bridge laboratory and clinical neuroscience.

 

Topic and format

Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on the following themes:

  • Neuroimmune Interactions in Health and Disease
  • Cellular and Molecular Pathways of Neuroinflammation
  • Neuroinflammation and Neurodegeneration: Cause or Consequence?
  • Innovative Imaging and Biomarkers for CNS Inflammation
  • Therapeutic Interventions Targeting Neuroinflammation
  • Role of Microglia and Astrocytes in Neuroinflammatory Diseases

 

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Section Editor: tanaka.masaru.1@med-u.szeged.hu.

The Section Editor jointly with the Editor-in-Chief will review all submissions and select those which will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

 

Dates and fees

 

We eagerly anticipate a diverse and truly global collection of papers and insights, driving scientific discovery and innovation to new heights on the world stage!